Thorncroft Center Takes the Lead in Equine Performance
Thorncroft was selected to test a new-patented delivery technology (TransEpi®) that demonstrated success in delivering topical vitamin D in people. Similar to human athletes, horses suffer from low vitamin D. The delivery technology avoids the stomach, which reduces vitamin D absorption and mimics the natural solar delivery of Vitamin D through the skin but without the sun. In people TransEpi® delivered vitamin D even when accompanied by sun protecting ingredients.
Top line results showed all of the horses in the study had substantial increases in Vitamin D, increased energy and improved mood after only 35 days of product application. "This study embodies Thorncroft's vision as a premier leader in enhancing the performance and wellness of horses and people" remarked Marge Gardner, CEO of Avidas Pharmaceuticals, the study’s sponsor. Avidas is collaborating with the Complete Equine Health Service in Coatsville, PA to publish the full study results.